On ECHEMI
Home > Drugs > Shandong Zibo Xinda Pharmaceutical Co., Ltd.

Shandong Zibo Xinda Pharmaceutical Co., Ltd.

  • Founded in:

    1993-03-11
  • Country:

    China China
  • Address:

    No. 1, Lutai Avenue, Zibo High-tech Zone
  • Tax NO.:

    9137030361328152XT
  • Registered Funds:

    84.93 million yuan
  • Website:

  • Email:

Related Drugs
Tinidazole Tablets
The main ingredient of this product is: tinidazole.
Name Description Content CAS NO. Registered Holders
Tinidazole

It has high activity against protozoa and anaerobic bacteria and can inhibit most anaerobic bacteria; microaerophilic bacteria and Helicobacter pylori are sensitive to it; its anti-amoeba mechanism is to inhibit its redox reaction, causing the protozoa's nitrogen chain to break, thereby killing the protozoa.

More

It has high activity against protozoa and anaerobic bacteria and can inhibit most anaerobic bacteria; microaerophilic bacteria and Helicobacter pylori are sensitive to it; its anti-amoeba mechanism is to inhibit its redox reaction, causing the protozoa's nitrogen chain to break, thereby killing the protozoa.

19387-91-8 14
Pimidic Acid Capsules
The main component of this product is pipemidic acid; its chemical name is: 8-ethyl-5-oxo-5,8-dihydro-2-(1-piperazinyl)pyrido[2,3-d]pyrimidine-6-carboxylic acid trihydrate. Molecular formula: C14H17N5O33H2O Molecular weight: 357.37
Name Description Content CAS NO. Registered Holders
Pipemidic acid

This product is a quinolone antibacterial drug, which has antibacterial effects on Gram-negative bacteria, such as Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Serratia, Salmonella typhi, Shigella, Pseudomonas aeruginosa, etc. This product acts on bacterial DNA gyrase, interfering with the synthesis of bacterial DNA, thereby causing bacterial death.

More

This product is a quinolone antibacterial drug, which has antibacterial effects on Gram-negative bacteria, such as Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Serratia, Salmonella typhi, Shigella, Pseudomonas aeruginosa, etc. This product acts on bacterial DNA gyrase, interfering with the synthesis of bacterial DNA, thereby causing bacterial death.

51940-44-4 3
Cephalexin Capsules
The main chemical component is cephalexin.
Name Description Content CAS NO. Registered Holders
Cephalexin

Cephalexin is a first-generation cephalosporin with an antibacterial spectrum similar to that of cephalothin, but its antibacterial activity is poorer than that of the latter. Except for Enterococcus and methicillin-resistant Staphylococci, most strains of Streptococcus pneumoniae, hemolytic Streptococcus, and Staphylococcus aureus that produces or does not produce penicillinase are sensitive to this product. This product has a good antibacterial effect on Neisseria, but Haemophilus influenzae is less sensitive to this product; this product has a certain antibacterial effect on some Escherichia coli, Proteus mirabilis, Salmonella and Shigella. The remaining Enterobacteriaceae, Acinetobacter, Pseudomonas aeruginosa, and Bacteroides fragilis are resistant to this product. Fusobacterium and Veillonella are generally sensitive to this product, and anaerobic Gram-positive cocci are moderately sensitive to this product.

More

Cephalexin is a first-generation cephalosporin with an antibacterial spectrum similar to that of cephalothin, but its antibacterial activity is poorer than that of the latter. Except for Enterococcus and methicillin-resistant Staphylococci, most strains of Streptococcus pneumoniae, hemolytic Streptococcus, and Staphylococcus aureus that produces or does not produce penicillinase are sensitive to this product. This product has a good antibacterial effect on Neisseria, but Haemophilus influenzae is less sensitive to this product; this product has a certain antibacterial effect on some Escherichia coli, Proteus mirabilis, Salmonella and Shigella. The remaining Enterobacteriaceae, Acinetobacter, Pseudomonas aeruginosa, and Bacteroides fragilis are resistant to this product. Fusobacterium and Veillonella are generally sensitive to this product, and anaerobic Gram-positive cocci are moderately sensitive to this product.

15686-71-2 33
Azithromycin Tablets
The main ingredient of this product is azithromycin.
Name Description Content CAS NO. Registered Holders
Azithromycin

Azithromycin is a 15-membered ring macrolide antibiotic that has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. It mainly binds to the 50S subunit of the bacterial ribosome and inhibits RNA-dependent protein synthesis.

More

Azithromycin is a 15-membered ring macrolide antibiotic that has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. It mainly binds to the 50S subunit of the bacterial ribosome and inhibits RNA-dependent protein synthesis.

83905-01-5 39
Cefaclor Granules
Cefaclor
Name Description Content CAS NO. Registered Holders
Cefaclor

This product is a broad-spectrum cephalosporin antibiotic. It has strong antibacterial effects on both Gram-negative bacteria. The mechanism of action is to kill bacteria by inhibiting the formation of bacterial cell walls. The bacteria and clinical isolates sensitive to it include Staphylococcus aureus, Haemophilus influenzae, Streptococcus pyogenes, Pneumococcus, Gonorrhea, Escherichia coli, Proteus mirabilis, Klebsiella, Propionibacterium acnes, Moraxella catarrhalis, Bacillus citrinum, Bacteroides, Peptococcus, Streptococcus peptidoglycans, etc. This product is highly stable to beta-lactamase and still has a strong killing effect on ampicillin-resistant strains (Staphylococcus aureus, Haemophilus influenzae, etc.) that produce beta-lactamase.

More

This product is a broad-spectrum cephalosporin antibiotic. It has strong antibacterial effects on both Gram-negative bacteria. The mechanism of action is to kill bacteria by inhibiting the formation of bacterial cell walls. The bacteria and clinical isolates sensitive to it include Staphylococcus aureus, Haemophilus influenzae, Streptococcus pyogenes, Pneumococcus, Gonorrhea, Escherichia coli, Proteus mirabilis, Klebsiella, Propionibacterium acnes, Moraxella catarrhalis, Bacillus citrinum, Bacteroides, Peptococcus, Streptococcus peptidoglycans, etc. This product is highly stable to beta-lactamase and still has a strong killing effect on ampicillin-resistant strains (Staphylococcus aureus, Haemophilus influenzae, etc.) that produce beta-lactamase.

53994-73-3 29
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.